EUVIMEDEUVIMED entdecken
Crossref

Hemodynamic Stability and Safety Profile of Prophylactic Intravenous Magnesium Sulphate in Spinal Anaesthesia: A Comparative Study of Two Dosing Regimens

Dr. Guru Prasaath, Dr. Chrish Lenil

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (19s)

DOI: 10.25258/ijddt.16.19s.86 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Dr. Guru Prasaath und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravenous Magnesium Sulphate is increasingly utilized as an adjuvant in spinal anaesthesia for its anti-shivering and potential analgesic properties. However, its pharmacological profile includes systemic vasodilation and calcium channel blockade, which raises concerns regarding intraoperative hemodynamic instability, specifically hypotension and bradycardia. While its efficacy in preventing shivering is established, the optimal prophylactic dose that balances anti-shivering efficacy with hemodynamic safety remains a subject of clinical debate.

Aim

To evaluate and compare the intraoperative hemodynamic stability and adverse effect profile of two different prophylactic doses of intravenous Magnesium Sulphate 25 mg/kg versus 50 mg/kg in patients undergoing surgeries under spinal anaesthesia.

Methods

This prospective observational study was conducted at a tertiary care centre over a period of 12 months. A total of 88 adult patients of ASA physical status I and II undergoing elective lower abdominal and lower limb surgeries under spinal anaesthesia were recruited. Patients were allocated into two groups: Group A received a 50 mg/kg IV Magnesium Sulphate bolus, and Group B received a 25 mg/kg IV Magnesium Sulphate bolus. Intraoperative hemodynamic parameters (Heart Rate, Systolic, Diastolic, and Mean Arterial Pressure) were monitored continuously. The primary outcomes assessed were the incidence of hemodynamic adverse events (hypotension, bradycardia), and secondary safety outcomes included nausea, vomiting, and respiratory depression. Statistical analysis was performed using SPSS version 20.0, with a p-value < 0.05 considered significant.

Results

The demographic profile was comparable between the two groups (p > 0.05). The incidence of intraoperative hypotension requiring intervention was observed in 13.6% (n=6) of patients in Group A (50 mg/kg) compared to 9.1% (n=4) in Group B (25 mg/kg), though this difference was not statistically significant (p = 0.50). Episodes of bradycardia were rare (4.5% vs 2.3%; p=0.55). The incidence of nausea was marginally higher in the high-dose group (6.8% vs 4.5%), but no episodes of respiratory depression or hypoxia were recorded in either group.

Conclusion

Prophylactic intravenous Magnesium Sulphate at both 25 mg/kg and 50 mg/kg maintains an acceptable safety profile during spinal anaesthesia in ASA I and II patients. The lower dose of 25 mg/kg demonstrates a hemodynamic stability profile comparable to the higher dose while effectively preventing shivering, making it a pragmatic choice for routine prophylaxis to minimize the theoretical risk of dose-dependent vasodilation.

Zitieren

APA

Prasaath, D. G., & Lenil, D. C. (2026). Hemodynamic Stability and Safety Profile of Prophylactic Intravenous Magnesium Sulphate in Spinal Anaesthesia: A Comparative Study of Two Dosing Regimens. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.86

Vancouver

Prasaath DG, Lenil DC. Hemodynamic Stability and Safety Profile of Prophylactic Intravenous Magnesium Sulphate in Spinal Anaesthesia: A Comparative Study of Two Dosing Regimens. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.86

BibTeX
@article{Prasaath2026,
  author = {Prasaath, Dr. Guru and Lenil, Dr. Chrish},
  title = {Hemodynamic Stability and Safety Profile of Prophylactic Intravenous Magnesium Sulphate in Spinal Anaesthesia: A Comparative Study of Two Dosing Regimens},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {19s},
  doi = {10.25258/ijddt.16.19s.86}
}
Kostenlos starten →